Skip to main content
. 2022 Jul;305:115068. doi: 10.1016/j.socscimed.2022.115068

Table 1.

Outcomes and costs (in US$ 2016) of home-based HIV counselling and testing, per testing round.

Round 1 Round 2 Round 3 Round 4 Round 5 Round 6 Round 7 Whole period (March 2012–April 2016)
Clusters opened 22 22 22 22 10 10 4 22
(a) No. of individuals registered 21,419 21,312 21,902 22,117 10,808 10,422 2918 28,347
(b) No. of contacts for HB-HCT 16,575 17,108 16,245 14,041 7982 7555 2105 81,611
(c) No. of contacts eligible for an HIV test 13,652 13,696 12,750 10,939 6186 5820 1761 64,804
(d) No. of HIV tests performed 10,627 10,713 9666 8263 4533 4127 1117 49,046
(e) No. of positive HIV tests 1254 873 523 477 231 134 18 3510
(f) No. of new HIV diagnoses 356 263 163 134 74 52 4 1046
(g) No. of appropriate referrals to HIV care 1846 1696 1401 1185 575 486 85 7274
Total cost 526,226.3 433,370.0 312,313.5 312,035.3 166,285.3 159,022.0 69,071.2 1,978,323.6
Cost per contact
Mean 32.0 25.1 19.2 22.2 20.8 21.0 32.8 24.2
(SD) (21.3) (13.0) (4.9) (6.6) (15.2) (5.4) (7.7) (13.7)
Median 21.4 19.7 19.6 19.9 15.4 19.1 36.8 19.8
(IQR) (19.8–30.5) (18.0–26.0) (14.8–23.4) (18.7–22.1) (14.2–19.7) (18.8–19.8) (36.6–37.1) (17.9–23.7)
Cost per contact eligible for an HIV test
Mean 38.5 31.6 24.5 28.5 26.9 27.3 39.2 30.5
(SD) (23.1) (15.2) (5.8) (7.1) (18.3) (6.5) (9.0) (15.4)
Median 27.8 25.0 24.6 26.5 20.7 26.4 43.7 25.4
(IQR) (24.7–44.4) (22.4–35.1) (19.4–29.4) (24.2–29.9) (18.6–23.2) (23.2–28.3) (43.3–44.3) (22.4–31.3)
Cost per HIV test performed
Mean 49.5 40.4 32.3 37.7 36.5 38.5 61.8 40.3
(SD) (30.8) (20.7) (8.6) (9.4) (23.2) (8.8) (15.8) (20.7)
Median 36.2 31.3 31.3 34.9 28.5 36.8 64.7 34.6
(IQR) (30.1–62.9) (28.4–45.7) (25.2–37.0) (31.8–38.3) (26.3–31.0) (34.4–40.3) (63.5–70.5) (28.8–40.5)
Cost per positive HIV test
Mean 412.0 489.7 586.9 614.1 691.3 1130.8 3579.6 546.9
(SD) (345.2) (413.5) (443.9) (483.8) (640.7) (825.6) (5159.2) (620.2)
Median 264.6 363.2 496.3 463.1 643.8 916.0 2433.6 376.0
(IQR) (228.2–466.0) (317.9–454.1) (281.8–621.0) (372.8–637.8) (341.2–667.3) (563.9–1532.6) (1140.8–3645.4) (275.5–621.0)
Cost per new HIV diagnosis
Mean 1430.7 1513.8 1698.8 2039.5 2122.7 2405.6 8110.3 1694.3
(SD) (1176.1) (1103.9) (1444.2) (1386.6) (2398.1) (2046.0) (8426.0) (1527.8)
Median 1041.4 1201.9 1505.4 1594.7 1319.6 1374.0 6323.7 1207.6
(IQR) (744.8–1531.0) (888.2–1710.3) (976.9–1737.0) (1173.0–2383.8) (764.7–2446.7) (1179.1–3041.2) (1711.2–14,509.3) (914.9–1906.7)
Cost per appropriate referral to HIV care
Mean 280.8 254.2 221.5 261.8 281.4 323.7 811.0 269.2
(SD) (358.7) (293.4) (124.5) (158.6) (341.3) (213.5) (499.9) (279.0)
Median 170.7 174.8 205.5 213.3 183.9 251.3 912.6 185.2
(IQR) (136.5–242.7) (140.5–237.3) (137.0–259.3) (166.4–291.6) (160.5–247.4) (220.2–371.7) (322.8–1063.7) (150.8–273.6)

Notes: Monetary amounts are provided in US$ (year 2016 values).

Definitions: (a) number of residents aged ≥16 years registered in the ANRS 12249 TasP trial (i.e., the target population eligible for HB-HCT, whose enumeration was updated at each survey round to account for in- and out-migration, individuals turning 16, and deaths), (b) number of contacts made by HIV counsellors to offer HB-HCT, (c) number of contacts eligible for an HIV test according to trial procedures (i.e., all contacts except those who self-reported being HIV-positive to the field worker), (d) number of rapid HIV tests performed, (e) number of positive rapid HIV tests, (f) number of new HIV diagnoses (contacts newly diagnosed as HIV positive, taking into account previous contacts and records in local governmental clinics), and (g) number of appropriate referrals to HIV care (i.e., contacts where the person was ascertained HIV positive through rapid testing or self-report, and was not currently in HIV care in a local governmental clinic or a trial clinic).

Abbreviations: HB-HCT = home-based HIV counselling and testing. SD = standard deviation. IQR = interquartile range.